Inger Nijhof

Research output

Research output per year 2012 2018 2019 2021 2022 2023 2024

• 25 Article
• 6 Review article
• 5 Letter
• 1 Comment/Letter to the editor

Research output per year

Research output per year

Search results

• 2024

  Additional booster doses in patients with chronic lymphocytic leukemia induce humoral and cellular immune responses to SARS-CoV-2 similar to natural infection regardless ongoing treatments: A study by ERIC, the European Research Initiative on CLL

  Campanella, A., Capasso, A., Heltai, S., Taccetti, C., Albi, E., Herishanu, Y., Haggenburg, S., Chatzikonstantinou, T., Doubek, M., Kättström, M., Giannopoulos, K., Simkovic, M., Moreno, C., Massaia, M., Bumbea, H., Alshemmari, S., Ranghetti, P., Perotta, E., Martini, F., Sant'Antonio, E., & 24 othersColia, M., Combi, C., Levi, S., Kater, A. P., Hazenberg, M., Nijhof, I. S., Hofsink, Q., Demosthenous, C., Kotaskova, J., Zaleska, J., Vrbacky, F., Raya, A. M., Bisogno, D., Tripoli, I. E., Popov, V. M., Roman, V., Stavroyianni, N., Karypidou, M., Scarano, E., Locatelli, M., Frenquelli, M., Scarfò, L., Stamatopoulos, K. & Ghia, P., Apr 2024, In: American journal of hematology. 99, 4, p. 745-750 6 p.

  Research output: Contribution to journal › Letter › Academic › peer-review

  Open Access
• 2021

  Potent Preclinical Efficacy of DuoHexaBody-CD37 in B-Cell Malignancies

  Van Der Horst, H. J., Oostindie, S. C., Cillessen, S. A. G. M., Gelderloos, A. T., Overdijk, M. B., Nijhof, I. S., Zweegman, S., Chamuleau, M. E. D., Breij, E. C. W. & Mutis, T., Jan 2021, In: HemaSphere. 5, 1, p. E504

  Research output: Contribution to journal › Letter › Academic › peer-review

  Open Access
  3 Citations (Scopus)
• 2020

  Effect of daratumumab on normal plasma cells, polyclonal immunoglobulin levels, and vaccination responses in extensively pre-treated multiple myeloma patients

  Frerichs, K. A., Bosman, P. W. C., van Velzen, J. F., Fraaij, P. L. A., Koopmans, M. P. G., Rimmelzwaan, G. F., Nijhof, I. S., Bloem, A. C., Mutis, T., Zweegman, S. & van de Donk, N. W. C. J., 1 Jun 2020, In: Haematologica. 105, 6, p. E302-E306 e302-e306.

  Research output: Contribution to journal › Letter › Academic › peer-review
  47 Citations (Scopus)
• 2019

  Impact of Fc gamma receptor polymorphisms on efficacy and safety of daratumumab in relapsed/refractory multiple myeloma

  van de Donk, N. W. C. J., Casneuf, T., Di Cara, A., Parren, P. W., Zweegman, S., van Kessel, B., Lokhorst, H. M., Usmani, S. Z., Lonial, S., Richardson, P. G., Chiu, C., Mutis, T., Nijhof, I. S. & Sasser, A. K., 1 Feb 2019, In: British journal of haematology. 184, 3, p. 475-479 5 p.

  Research output: Contribution to journal › Letter › Academic › peer-review
  17 Citations (Scopus)
• 2018

  Cereblon loss and up-regulation of c-Myc are associated with lenalidomide resistance in multiple myeloma patients

  Franssen, L. E., Nijhof, I. S., Couto, S., Levin, M. D., Bos, G. M. J., Broijl, A., Klein, S. K., Ren, Y., Wang, M., Koene, H. R., Bloem, A. C., Beeker, A., Faber, L. M., van der Spek, E., Raymakers, R., Leguit, R. J., Sonneveld, P., Zweegman, S., Lokhorst, H., Mutis, T., & 3 othersThakurta, A., Qian, X. & van de Donk, N. W. C. J., 31 Jul 2018, In: Haematologica. 103, 8, p. e368-e371

  Research output: Contribution to journal › Letter › Academic › peer-review

  Open Access
  43 Citations (Scopus)